Contact Us Today|info@empharmd.com

Trick of the Trade: Quick & Painless Ampule and Filter Needle Technique

Standard technique for transferring a medication from a glass ampule involves swabbing the ampule with isopropyl alcohol and breaking the neck of the ampule with the alcohol pad or gauze. The problem that many can attest to is the glass breaking in a way that punctures through the pad or gauze and cuts into one’s digits.Not only is this a painful issue, but there are other considerations when a member of the team cuts themselves: [...]

By |2017-01-04T11:00:00-05:00January 4th, 2017|EM PharmD Blog|0 Comments

Trick of the Trade: Quick & Painless Ampule and Filter Needle Technique

Standard technique for transferring a medication from a glass ampule involves swabbing the ampule with isopropyl alcohol and breaking the neck of the ampule with the alcohol pad or gauze. The problem that many can attest to is the glass breaking in a way that punctures through the pad or gauze and cuts into one’s digits.Not only is this a painful issue, but there are other considerations when a member of the team cuts themselves: [...]

By |2017-01-04T11:00:00-05:00January 4th, 2017|EM PharmD Blog|0 Comments

Top 10 Posts of 2016

2016 proved to be a fantastic year for Emergency Medicine PharmD. We have shared a lot of great content with you, and we hope to maintain our trajectory within the world of #FOAMed. Below are the top 10 posts in view count published this year on the blog: Trick of the Trade: Diphenhydramine for Local Anesthesia Author: Nadia Awad, PharmD, BCPS (@Nadia_EMPharmD) No More Epinephrine Ratios! Author: Craig Cocchio, PharmD, BCPS (@iEMPharmD) Managing Rate Control [...]

By |2016-12-28T11:00:00-05:00December 28th, 2016|EM PharmD Blog|0 Comments

Early Pharmacotherapy Management for the Potential Organ Donor in the Trauma Bay

Thinking ahead is something most EM pharmacists are excellent at and we are – amongst other things – in the business of saving lives. On the (hopefully) rare occasion that the 30-something-year-old trauma patient rolls in with a blatantly obvious and observable poor prognosis, being steps ahead may be doing just that. In the back of your mind, you think this otherwise healthy patient could potentially be an organ donor. In the immediate, sense you [...]

By |2016-12-14T11:00:00-05:00December 14th, 2016|EM PharmD Blog|0 Comments

Debates in the Management of Hyperkalemia

At the 2016 Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists (ASHP), my colleague Bryan Hayes (@PharmERToxGuy) and I presented a continuing education program on debates in the management of hyperkalemia. The learning objectives from our session are below: Evaluate recommendations for dosing and administration of parenteral calcium in the treatment of hyperkalemia.  Apply practical methods for co-administration of insulin and dextrose in the management of hyperkalemia. Discuss evidence-based literature surrounding administration of [...]

By |2016-12-08T01:00:00-05:00December 8th, 2016|EM PharmD Blog|0 Comments

How the NEJM and Star Wars May Just Have Predicted My Future in #FOAMed

It sometimes is a bit wondrous how our past actions can influence how our future pursuits. I have discussed how #FOAMed has made an impact on research, discovery, and my professional pursuits here and here. To be quite frank, I can't imagine how my life would be if I was not engaged in social media. But obviously, at one point, I did, and I may have predicted my own engagement in #FOAMed without even realizing [...]

By |2016-11-28T11:00:00-05:00November 28th, 2016|EM PharmD Blog|0 Comments

A New “Lytic” Controversy: This One Isn’t Full of Sh*t. Docusate As a Ceruminolytic

In my opinion, pharmacist "interventions" are a bad thing. While there are many reasons behind this, but I prefer creating a culture of open, prospective discussion rather than reactive drug policing. If I approach a prescriber in the ED, I'm greeted with "What did I do now?" I'm doing something wrong. Discussing new papers, institutional protocols, sharing interesting patient cases, or you know, general human-to-human conversations are great opportunities for taking about drug therapy approaches, new [...]

By |2016-10-12T17:44:00-05:00October 12th, 2016|EM PharmD Blog|0 Comments

A New "Lytic" Controversy: This One Isn't Full of Sh*t. Docusate As a Ceruminolytic

In my opinion, pharmacist "interventions" are a bad thing. While there are many reasons behind this, but I prefer creating a culture of open, prospective discussion rather than reactive drug policing. If I approach a prescriber in the ED, I'm greeted with "What did I do now?" I'm doing something wrong. Discussing new papers, institutional protocols, sharing interesting patient cases, or you know, general human-to-human conversations are great opportunities for taking about drug therapy approaches, new [...]

By |2016-10-12T17:44:00-05:00October 12th, 2016|EM PharmD Blog|0 Comments

Idarucizumab: An Imperfect Reversal Agent for Dabigatran

We waited with bated breath for idarucizumab, the antidote for dabigatran, to be approved by the FDA. We heard whispers that it was coming for a number of years, even during those rough first few relatively recent years following the approval and widespread use of dabigatran, during which time patients presented to emergency departments across the globe with life-threatening bleeding secondary to dabigatran. Craig and I discussed it in our podcast episode on pipeline reversal [...]

By |2016-09-10T10:00:00-05:00September 10th, 2016|EM PharmD Blog|0 Comments

Is It Time to Ditch Isoproterenol for Bradycardia?

The acquisition cost of isoproterenol (Isuprel®) has dramatically increased from approximately $60 per vial in 2012 to over $2,150 per vial today, a nearly 4000% increase. In order to minimize costs associated with therapy, the following represents alternative agents that may be utilized in the management of bradyarrhythmia:Recommendations for the management of bradyarrhythmia based on the Advanced Cardiovasular Life Support guidelines are as follows (1):Patients who are asymptomatic from their bradycardia typically do not need aggressive [...]

By |2016-08-30T10:00:00-05:00August 30th, 2016|EM PharmD Blog|0 Comments